Savior Lifetec Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAVIOR LIFETEC CORP
SAVIOR LIFETEC CORP has two approved drugs.
Drugs and US Patents for Savior Lifetec Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savior Lifetec Corp | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206086-001 | Apr 19, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Savior Lifetec Corp | ERTAPENEM SODIUM | ertapenem sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 207647-001 | Mar 19, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Savior Lifetec Corp | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206086-002 | Apr 19, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

